Boston Scientific has bought Emcision, a spinout from Imperial College London that is developing a range of surgical instruments.
Emcision, a UK-based medical device spinout from Imperial College London, has been acquired by medical device manufacturer Boston Scientific for an undisclosed sum.
Founded in 1999, Emcision has developed a range of surgical instruments that rely on radiofrequency energy. The devices are aimed at percutaneous procedures – the method of accessing organs through a needle-puncture of the skin – as well as open, minimally invasive, vascular and endoscopic surgeries.
The company’s products include the Habib EndoHPB probe, an endoscopic bipolar…
